ZIOP

ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma

[at noodls] – Restructuring to Place Exclusive Strategic Focus on Synthetic Biology Programs Company to Host Conference Call Today, March 26, 2013 at 8:30 AM ET NEW YORK, March 26, 2013 (GLOBE NEWSWIRE) — ZIOPHARM … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here […]

ZIOPHARM Oncology Initiates Phase 2 Study of Ad-RTS IL-12 and Palifosfamide Combination for Treatment of Advanced Breast Cancer

[at noodls] – NEW YORK, March 11, 2013 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here to view […]

ZIOPHARM Oncology to Present at the Barclays Global Healthcare Conference

[at noodls] – NEW YORK, March 7, 2013 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the Barclays Global Healthcare … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here to view […]

Phase 3 Trial of ZIOPHARM’S Palifosfamide in First-Line Metastatic Soft Tissue Sarcoma Reaches Target Number of Progression-Free Survival Events

[at noodls] – NEW YORK, Feb. 12, 2013 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here to view […]

Solasia Announces New Executive Leadership, Clinical Activities, and China Operations

[Business Wire] – TOKYO–(BUSINESSWIRE)– Solasia Pharma K.K. announced today a change in its executive leadership team. Yoshihiro Arai, currently General Manager and Head of Development of Solasia Pharma K.K., has been … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here to view […]

ZIOPHARM Oncology to Present at the 15th Annual BIO CEO & Investor Conference

[at noodls] – NEW YORK, Feb. 6, 2013 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the 15th Annual BIO CEO & Investor … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here […]

ZIOPHARM Oncology to Present at the 31st Annual J.P. Morgan Healthcare Conference

[at noodls] – NEW YORK, Jan. 3, 2013 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the 31st Annual J.P. Morgan Healthcare … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here to […]